In-vitro Fertilization Devices are becoming highly popular as they aid patients in convening baby with optimum safety for the couple

 

The use of in-vitro fertilization to help treat infertility is a relatively new treatment option for many couples who struggle to conceive. There have been a number of advances in fertility treatments over the past several years; however, nothing has yet come close to the success rate offered by In-vitro Fertilization Devices. For those seeking a solution to their infertility problems, the use of an In-vitro Fertilization Device can offer a permanent solution with little effort or risk involved. The process begins by collecting primary healthy sperm from a male donor, then inducing the semen into the woman's vagina. Once this is achieved, the In-vitro Fertilization Device is then used to provide stimulating stimulation to the uterus and ovaries, resulting in pregnancy.

Although many fertility clinics offer in-vitro fertilization devices, the market is not as competitive as many fertility clinics would like it to be. Many clinics have moved away from performing IVF's due to the high success rates and extensive medical care required to maintain the pregnancy once the procedure was performed. Due to these factors, clinics are often only offering In-vitro fertilization devices to patients that are undergoing all forms of infertility treatment including Clomid, IUI, and egg/seminal transfer. However, many patients turn to In-vitro Fertilization Devices when they no longer wish to take costly fertility medications and require more personalized treatment options. Some couples actually prefer the procedure so much that they end up making two separate fertilization using the same In-vitro Fertilization Device, which allows them to ensure they receive the maximum chance for conception.

As stated earlier, the first step to achieve successful fertilization is for the patient to undergo testing to determine the most favorable time frame to begin In-vitro Fertilization Therapy. This testing is performed by both a fertility clinic medical staff and an in-vitro fertilization technician. Once the medical team determines the ideal time frame to begin therapy, the technicians will then begin harvesting eggs from the woman's ovaries. Eggs will then be examined under a microscope to determine the number of chromosomes carried by each egg, this process is known as the follicle-stimulating factor (FSF). Recently, in July 2018, Merck launched QBOX IVF and the new Geri Assess 2.0, which enables automatic detection of key events in embryos.